Moderna Capitalizes On Its Headstart In COVID-19 Vaccines
Leaked List Shows Premium Price Secured With EU
Executive Summary
The US biotech has booked orders of nearly 500 million doses for its COVID-19 vaccine, and a leaked price list from Europe shows it has secured a premium price ahead of all its rivals, including Pfizer/BioNTech.
You may also be interested in...
CureVac Enlists Bayer To Secure Place Among COVID-19 Vaccines ‘Second Wave’
While demand for COVID-19 vaccines will be huge for the next two years, only those players with major manufacturing and commercial infrastructures in place will play a big role.
Coronavirus Update: Moderna Snags Vaccine EUA
The FDA granted emergency authorization for Moderna's mRNA-1273 following a 17 December advisory committee vote in its favor. There have also been more supply deals and approvals in Asia.
Novartis Nominates Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.